Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: An updated systematic review
10.1136/svn-2017-000112
Saved in:
Main Authors: | Wang X., You S., Sato S., Yang J., Carcel C., Zheng D., Yoshimura S., Anderson C.S., Sandset E.C., Robinson T., Chalmers J., Sharma V.K. |
---|---|
Other Authors: | YONG LOO LIN SCHOOL OF MEDICINE |
Format: | Review |
Published: |
BMJ Publishing Group
2019
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/151785 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in acute ischemic stroke
by: Loh, P.K., et al.
Published: (2016) -
Comment on "efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke"
by: Ahmad, A., et al.
Published: (2016) -
Low-dose versus standard-dose tissue plasminogen activator for intravenous thrombolysis in asian acute ischemic stroke patients
by: Ng, K.W.P., et al.
Published: (2016) -
Pulse pressure variability is associated with unfavorable outcomes in acute ischaemic stroke patients treated with intravenous thrombolysis
by: Katsanos, AH, et al.
Published: (2021) -
Stress Hyperglycaemia is Associated with Poor Functional Outcomes in Patients with Acute Ischaemic Stroke after Intravenous Thrombolysis
by: Ngiam, JN, et al.
Published: (2020)